Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
J Gen Intern Med. 2019 Nov;34(11):2586-2591. doi: 10.1007/s11606-019-04860-8. Epub 2019 Jun 13.
Discussing the uncertainty associated with a clinical decision is thought to be a critical element of shared decision-making. Yet, empirical evidence suggests that clinicians rarely communicate clinical uncertainty to patients, and indeed the culture within healthcare environments is often to equate uncertainty with ignorance or failure. Understanding the rationale for discussion of uncertainty along with the current evidence about approaches to communicating and managing uncertainty can advance shared decision-making as well as highlight gaps in evidence. With an increasing focus on personalized healthcare, and advances in genomics and new disease biomarkers, a more sophisticated understanding of how to communicate the limitations and errors that come from applying population-based, epidemiologic findings to predict individuals' futures is going to be essential. This article provides a narrative review of studies relating to the communication of uncertainty, highlighting current strategies together with challenges and barriers, and outlining a framework for future research.
讨论临床决策相关的不确定性被认为是共同决策的一个关键要素。然而,实证证据表明,临床医生很少向患者传达临床不确定性,实际上,医疗环境中的文化往往将不确定性等同于无知或失败。了解讨论不确定性的基本原理以及当前关于沟通和管理不确定性的方法的证据,可以促进共同决策,并突出证据中的差距。随着个性化医疗的日益关注,以及基因组学和新疾病生物标志物的进步,更深入地了解如何沟通应用基于人群的流行病学研究结果来预测个体未来时所带来的局限性和误差将变得至关重要。本文对与不确定性沟通相关的研究进行了叙述性综述,重点介绍了当前的策略以及挑战和障碍,并为未来的研究勾勒出了一个框架。